Modified erythropoietin (EPO) with reduced immunogenicity

Details for Australian Patent Application No. 2002250889 (hide)

Owner MERCK PATENT GMBH

Inventors Carr, Francis J.; Jones, Tim; Williams, Stephen; Carter, Graham

Agent Davies Collison Cave

Pub. Number AU-A-2002250889

PCT Pub. Number WO2002/062843

Priority 01103954.2 19.02.01 EP; 01102615.0 06.02.01 EP

Filing date 5 February 2002

Wipo publication date 19 August 2002

International Classifications

C07K 014/575 Peptides having more than 20 amino acids

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002250889

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002250890-TRIPEPTIDES AND TRIPEPTIDE DERIVATIVES FOR THE TREATMENT OF POSTLESIONAL DISEASES OF THE NERVOUS SYSTEM

2002250888-DEVICE FOR AFFECTING ROOMS OR COMPONENTS THEREOF